We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.78B
AUM Growth
-$68.3M
Cap. Flow
-$132M
Cap. Flow %
-7.44%
Top 10 Hldgs %
16.28%
Holding
390
New
41
Increased
102
Reduced
174
Closed
34

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.23M
2
ASRT
Assertio
ASRT
+$8.76M
3
ITMN
INTERMUNE INC
ITMN
+$8.58M
4
EPZM
Epizyme, Inc
EPZM
+$8.51M
5
KFRC icon
Kforce
KFRC
+$8.18M

Top Sells

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$40.2M
2
AKRX
Akorn Inc
AKRX
+$21.7M
3
BCOV
Brightcove, Inc.
BCOV
+$10.6M
4
REXX
Rex Energy Corporation
REXX
+$8.91M
5
MTH icon
Meritage Homes
MTH
+$8.41M

Sector Composition

Rank Sector Weight
1 Industrials 17.87%
2 Technology 15.37%
3 Healthcare 14.23%
4 Financials 11.54%
5 Consumer Discretionary 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MON
376
DELISTED
Monsanto Co
MON
– –
-1,808
Closed -$211K
CAA
377
DELISTED
CalAtlantic Group, Inc.
CAA
– –
-4,605
Closed -$208K
UNXL
378
DELISTED
Uni-Pixel, Inc.
UNXL
– –
-94,513
Closed -$946K
DD
379
DELISTED
Du Pont De Nemours E I
DD
– –
-3,399
Closed -$210K
JIVE
380
DELISTED
Jive Software, Inc.
JIVE
– –
-178,736
Closed -$2.01M
RYL
381
DELISTED
RYLAND GROUP INC
RYL
– –
-39,853
Closed -$1.73M
GEVA
382
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-78,545
Closed -$5.08M
MDVN
383
DELISTED
MEDIVATION, INC.
MDVN
– –
-53,080
Closed -$1.69M
HAWK
384
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
– –
-190,976
Closed -$4.82M
12 13 14 15
16

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Emerald Advisers held 390 positions worth $1.78B, down 3.7% from $1.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Emerald Advisers withdrew a net $132M in Q1 2014, closing 34 positions and reducing 174 holdings. Its most notable exit was Akorn Inc, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Emerald Advisers opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $12.4M.

  • Emerald Advisers's largest Q1 2014 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 817,410 shares worth $12.4M.
  • Emerald Advisers added most to PacWest Bancorp in Q1 2014, an estimated $7.25M increase.
  • Emerald Advisers's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $40.2M.
  • Emerald Advisers fully exited Akorn Inc in Q1 2014, selling an estimated $21.7M.
  • Emerald Advisers's ten largest holdings make up 16% of its $1.78B portfolio in Q1 2014.
  • Emerald Advisers opened 41 new positions and closed 34 in Q1 2014.
  • Emerald Advisers's portfolio value fell 3.7% quarter-over-quarter to $1.78B.

Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.